IL21-AS1: A Potential Drug Target and Biomarker (G100996941)

IL21-AS1: A Potential Drug Target and Biomarker

IL21-AS1 (Interleukin-21- associated protein-1) is a protein that is expressed in various tissues of the body, including immune cells, epithelial cells, and neural cells. It is a member of the IL21 family of cytokines, which play a crucial role in the regulation of immune and inflammatory responses. The identification of IL21-AS1 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases.

IL21-AS1 Functions as a Signaling molecule

IL21-AS1 is a cytokine that is involved in the regulation of immune responses, inflammation, and cell survival. It is a potent stimulator of the production of pro-inflammatory cytokines, such as IL-1尾, IL-2, and IL-18. IL21-AS1 can also induce the production of anti-inflammatory cytokines, such as IL-10. These cytokines play a crucial role in the regulation of immune responses, tissue repair, and inflammation.

IL21-AS1 is also involved in the regulation of cell survival and proliferation. It can induce cell proliferation and promote the survival of cancer cells. The high level of IL21-AS1 expression in cancer cells makes them more resistant to chemotherapy and radiation therapy.

IL21-AS1 as a Potential Drug Target

The identification of IL21-AS1 as a potential drug target has significant implications for the development of new treatments for various diseases. One of the main targets of IL21-AS1 is the regulation of immune responses. IL21-AS1 can stimulate the production of pro-inflammatory cytokines, which can contribute to the development of inflammatory diseases, such as rheumatoid arthritis, asthma, and multiple sclerosis.

IL21-AS1 can also promote the development of cancer by stimulating the production of anti-inflammatory cytokines and promoting the survival of cancer cells. Therefore, targeting IL21-AS1 with drugs that inhibit its function could be an effective way to treat cancer.

IL21-AS1 as a Biomarker

IL21-AS1 can also be used as a biomarker for the diagnosis and monitoring of various diseases. For example, high levels of IL21-AS1 expression can be used as a marker for the diagnosis of rheumatoid arthritis, a type of inflammatory arthritis that affects the joints. Similarly, IL21-AS1 expression can be used as a marker for the diagnosis of asthma, a type of respiratory disease that is characterized by inflammation and swelling of the airways.

IL21-AS1 has also been used as a biomarker for the monitoring of various diseases, such as cancer. The levels of IL21-AS1 expression can be used to assess the effectiveness of anti-cancer treatments and to monitor the progression of cancer.

Conclusion

IL21-AS1 is a protein that is involved in the regulation of various physiological processes in the body. Its functions as a signaling molecule and biomarker make it an attractive target for the development of new treatments for various diseases. The inhibition of IL21-AS1 function with drugs could be an effective way to treat cancer and other diseases. Further research is needed to fully understand the role of IL21-AS1 as a drug target and biomarker.

Protein Name: IL21 Antisense RNA 1

The "IL21-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL21-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

IL21R | IL21R-AS1 | IL22 | IL22RA1 | IL22RA2 | IL23A | IL23R | IL24 | IL25 | IL26 | IL27 | IL27RA | IL2RA | IL2RB | IL2RG | IL3 | IL31 | IL31RA | IL32 | IL33 | IL34 | IL36A | IL36B | IL36G | IL36RN | IL37 | IL3RA | IL4 | IL4I1 | IL4R | IL5 | IL5RA | IL6 | IL6-AS1 | IL6R | IL6R-AS1 | IL6ST | IL6ST-DT | IL6STP1 | IL7 | IL7R | IL9 | IL9R | IL9RP3 | IL9RP4 | ILDR1 | ILDR2 | ILF2 | ILF3 | ILF3-DT | ILK | ILKAP | ILRUN | ILVBL | Imidazoline I2 receptor (I2) | Imidazoline I3 receptor (I3) | Imidazoline receptor | IMMP1L | IMMP2L | IMMT | IMMTP1 | Immunoglobulin A | Immunoglobulin E (IgE) | Immunoglobulin G | Immunoglobulin M | Immunoglobulin-Like Domain Containing Receptor | Immunoproteasome | IMP3 | IMP4 | IMPA1 | IMPA1P1 | IMPA2 | IMPACT | IMPDH1 | IMPDH1P10 | IMPDH1P6 | IMPDH2 | IMPG1 | IMPG2 | INA | INAFM1 | INAFM2 | INAVA | INCA1 | INCENP | INE1 | INE2 | INF2 | ING1 | ING2 | ING2-DT | ING3 | ING4 | ING5 | INGX | INHA | INHBA | INHBA-AS1 | INHBB | INHBC